Deliver Your News to the World

Solvay Pharmaceuticals, Inc. Baudette Plant Awarded Governor’s Safety Award


June 6, 2006

Marietta, Ga. – Solvay Pharmaceuticals, Inc. announced today that its Baudette, Minn. manufacturing facility received a Governor’s Safety Award from the Minnesota Safety Council for excellence in workplace safety and health.

“The safety and health of our employees is a top priority in everything we do,” said Mike Dornhecker, vice president of manufacturing and operations, Solvay Pharmaceuticals, Inc. “This award from the Minnesota Safety Council is a testament to the efforts of each and every employee to help make our facility a safe working environment.”

“On average, nearly 300 Minnesota workers are injured or become ill from job-related causes each day,” said Carol Bufton, president of the Minnesota Safety Council. “Smart employers like Solvay Pharmaceuticals understand that a commitment to safety contributes to the health of their employees and the bottom line.”

Solvay Pharmaceuticals is one of 191 employers (out of 447 applicants) who were recognized at a recent luncheon at the Minneapolis Convention Center. Since 1934, the annual Governor’s Safety Awards have spotlighted Minnesota employers with above average safety records. Participants submit injury information which is compared with state and national data, as well as the entrant’s past performance. Ongoing safety programs and activities are also considered.

Solvay Pharmaceuticals’ health, safety and environmental (HSE) program is designed to protect employees, customers, contractors and the public. The company is committed to compliance with all laws and regulations; continuous improvement in HSE performance with the ultimate goal of zero accidents, occupational illnesses, injuries or harm to the environment; timely measurement and reporting of HSE performance and continuous employee training and education. HSE also ensures that facilities are built, operated and maintained to protect the health and safety of employees, the surrounding community and environment.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, specialized markets and men’s and women’s health. Its 2005 sales were EUR 2.3 billion and it employs approximately 10 000 people worldwide. For more information, visit

Solvay is an international chemicals and pharmaceuticals group with headquarters in Brussels. It operates in more than 50 countries, with some 30,000 employees. In 2005 its consolidated sales amounted to EUR 8.6 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay SA is listed on the Euronext 100 index of top European companies. Details are available at

# # #


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.